{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-080602","form_type":"8-K","ticker":"INM","cik":"0001728328","company_name":"InMed Pharmaceuticals Inc.","filed_at":"2022-12-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.906046+00:00","generated_at":"2026-06-21T03:27:44.816922+00:00","sec_items":["5.07","7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"InMed shareholders elect all director nominees and appoint Marcum LLP as auditor at 2022 AGM","bullets":["All five director nominees elected: Eric A. Adams (94.90%), Andrew Hull (94.34%), Janet Grove (96.70%), Bryan Baldasare (95.82%), Nicole Lemerond (96.66%).","Marcum LLP appointed as independent registered public accounting firm with 97.68% votes in favor.","All proposals approved by shareholders at December 15, 2022 annual meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-080602","json":"https://secwatch.observer/filing/0001213900-22-080602.json","markdown":"https://secwatch.observer/filing/0001213900-22-080602.md","text":"https://secwatch.observer/filing/0001213900-22-080602.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1728328/000121390022080602/0001213900-22-080602-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1728328/000121390022080602/ea170383-8k_inmedpharma.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T03:27:44.816922+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3904bb7b9ae5505660314b48b62a1e34d3a4eb24","claim":"InMed Pharmaceuticals Inc. shareholders approved Appointment of Independent Registered Public Accounting Firm at the 2022-12-15 meeting.","evidence_excerpt":"Proposal No. 2—Appointment of Independent Registered Public Accounting Firm The Corporation’s shareholders voted to approve the appointment of Marcum LLP as the independent registered public accounting firm of the Corporation until the 2023 Annual General Meeting of Shareholders or until a successor is named. Votes For % Votes For Vote Against % Votes Against Abstain Broker Non-Votes 339,548 97,68% 0 0% 8,047 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1728328/000121390022080602/0001213900-22-080602-index.htm","confidence":0.95,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2022-12-15"}],"fact_type":"shareholder_vote"},{"claim_id":"f7fe6e2c49dfa8a9c118c65faaada9f0f77e1d91","claim":"InMed Pharmaceuticals Inc. shareholders approved Election of Directors at the 2022-12-15 meeting.","evidence_excerpt":"Proposal No. 1—Election of Directors The Corporation’s shareholders voted to elect the following persons to the board of directors of the Corporation, each to serve until the 2023 Annual General Meeting of Shareholders: Nominee Votes For % Votes For Votes Withheld % Votes Withheld Broker Non-Votes Eric A. Adams 159,223 94.90 % 8,559 5.10 % 179,813 Andrew Hull 158,282 94.34 % 9,500 5.66 % 179,813 Janet Grove 162,246 96.70 % 5,536 3.30 % 179,813 Bryan Baldasare 160,764 95.82 % 7,018 4.18 % 179,813 Nicole Lemerond 162,174 96.66 % 5,608 3.34 % 179,813","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1728328/000121390022080602/0001213900-22-080602-index.htm","confidence":0.95,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2022-12-15"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}